CLINICAL SUPPLY MANAGEMENT ARTICLES
How AI Can Improve Clinical Supply Chain Visibility
AI can help clinical supply teams identify risks earlier, improve forecasting, and make faster, more informed decisions before disruptions affect trial continuity.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
Rachel Curran, Head of Sourcing Services and Special Accounts, discusses the requirements, challenges, and solutions to comparator and co-therapy drug sourcing for clinical trials.
-
Examine how the next generation of therapies is disrupting supply chain logistics and explore solutions for the complexities within cell and gene therapies.
-
Do pharma companies underestimate supply chain challenges? Much can go wrong when sending a therapy from A to B, but the right collaborations can mitigate risk.
-
Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
-
Patient enrollment can vary widely due to a number of variables, introducing risk into the supply chain. Here's why its critical to be aware of these risks and how best to mitigate them within trials.